Home Newsfeeds Cvent Holding Corp Rejects $8 Per Share Acquisition Offer From Blackstone Inc

Cvent Holding Corp Rejects $8 Per Share Acquisition Offer From Blackstone Inc

– Reuters Citing Sources

byHappy Mohamed

February 24, 2023

1 minute read

– Reuters Citing Sources

Guggenheim Initiates Coverage On Albireo Pharma with Buy Rating, Announces Price Target of $55

By Benzinga Newsdesk

September 8, 8:34 AM

Guggenheim analyst Seamus Fernandez initiates coverage on Albireo Pharma (NASDAQ:ALBO) with a Buy rating and announces Price Target of $55.

ALBO

Why XPeng Stock Is Popping Off After Tesla Earnings

By Henry Khederian

January 26, 3:30 PM

XPeng Inc - ADR (NYSE: XPEV) shares are trading higher by 4.81% to $10.24 Thursday afternoon. Shares of EV companies at large are trading higher during Thursday's session. Strength in the sector may be in sympathy with Tesla Inc (NASDAQ:

TSLA

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study

By Vandana Singh

April 18, 1:44 PM

Discover toplines results of Cerevel Therapeutics' Phase 3 TEMPO-3 trial for tavapadon in Parkinson's disease treatment. Statistically significant efficacy and safety findings were revealed.

ABBV

accesso Passport Inks Expanded Five-Year Extension With Cedar Fair

By Benzinga Newsdesk

November 9, 9:14 AM

accesso Technology Group plc (AIM: ACSO), the premier technology solutions provider for attractions and venues worldwide, has finalized a five-year extension expanding its partnership with Cedar Fair

FUN

Cvent Holding Corp Rejects $8 Per Share Acquisition Offer From Blackstone Inc

Related Posts

Guggenheim Initiates Coverage On Albireo Pharma with Buy Rating, Announces Price Target of $55

Why XPeng Stock Is Popping Off After Tesla Earnings

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study

accesso Passport Inks Expanded Five-Year Extension With Cedar Fair